These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33841389)

  • 1. Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
    Perumal P; Abdullatif MB; Garlant HN; Honeyborne I; Lipman M; McHugh TD; Southern J; Breen R; Santis G; Ellappan K; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan SS; Joseph N; Kempsell KE
    Front Immunol; 2020; 11():612564. PubMed ID: 33841389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis.
    Garlant HN; Ellappan K; Hewitt M; Perumal P; Pekeleke S; Wand N; Southern J; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan S; Joseph NM; Kempsell KE
    Front Immunol; 2022; 13():854327. PubMed ID: 35720382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
    Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
    Front Immunol; 2019; 10():2948. PubMed ID: 31921195
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of Activation Markers by Mycobacterium tuberculosis-specific CD4+ T Cell Distinguishes Extrapulmonary From Pulmonary Tuberculosis and Latent Infection.
    Silveira-Mattos PS; Barreto-Duarte B; Vasconcelos B; Fukutani KF; Vinhaes CL; Oliveira-De-Souza D; Ibegbu CC; Figueiredo MC; Sterling TR; Rengarajan J; Andrade BB
    Clin Infect Dis; 2020 Nov; 71(8):1905-1911. PubMed ID: 31665254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures.
    Warsinske H; Vashisht R; Khatri P
    PLoS Med; 2019 Apr; 16(4):e1002786. PubMed ID: 31013272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection.
    Xi X; Wang B; Zhang R; Ling C
    J Microbiol Methods; 2024 Jul; 222():106944. PubMed ID: 38705210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of
    Xie L; Zhu G; Long S; Wang M; Cheng X; Dong Y; Wang C; Wang G
    Ann Med; 2024 Dec; 56(1):2380797. PubMed ID: 39054612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis.
    Ma S; Peng P; Duan Z; Fan Y; Li X
    J Immunol Res; 2023; 2023():7829286. PubMed ID: 37228444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein and Microbial Biomarkers in Sputum Discern Acute and Latent Tuberculosis in Investigation of Pastoral Ethiopian Cohort.
    HaileMariam M; Yu Y; Singh H; Teklu T; Wondale B; Worku A; Zewude A; Mounaud S; Tsitrin T; Legesse M; Gobena A; Pieper R
    Front Cell Infect Microbiol; 2021; 11():595554. PubMed ID: 34150670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
    Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
    Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
    Natarajan S; Ranganathan M; Hanna LE; Tripathy S
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
    Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
    Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-transcriptome sequencing of phagocytes reveals a ceRNA network contributing to natural resistance to tuberculosis infection.
    Ran F; Wang Y; Zhang G; Guo H; Li J; Zhang X; Wu Z; Bi L
    Microb Pathog; 2024 Jul; 192():106681. PubMed ID: 38754565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
    Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
    Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.